{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T08:56:56Z","timestamp":1784192216215,"version":"3.55.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2005,5,20]],"date-time":"2005-05-20T00:00:00Z","timestamp":1116547200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefe's Arch Clin Exp Ophthalmo"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1007\/s00417-005-1178-x","type":"journal-article","created":{"date-parts":[[2005,5,19]],"date-time":"2005-05-19T11:13:06Z","timestamp":1116501186000},"page":"999-1004","source":"Crossref","is-referenced-by-count":12,"title":["Prevalence of parvovirus B19-specific antibodies and of viral DNA in patients with endogenous uveitis"],"prefix":"10.1007","volume":"243","author":[{"given":"Carsten","family":"Heinz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelie","family":"Plentz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnd","family":"Heiligenhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Modrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,5,20]]},"reference":[{"issue":"2","key":"1178_CR1","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0002-9394(14)74235-7","volume":"103","author":"E Bloch-Michel","year":"1987","unstructured":"Bloch-Michel E, Nussenblatt RB (1987) International uveitis study group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol 103(2):234\u2013235","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"1178_CR2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1099\/00222615-25-2-151","volume":"25","author":"BJ Cohen","year":"1988","unstructured":"Cohen BJ, Buckley MM (1988) The prevalence of antibody to human parvovirus B19 in England and Wales. J Med Microbiol 25(2):151\u2013153","journal-title":"J Med Microbiol"},{"issue":"Pt 6","key":"1178_CR3","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1099\/jmm.0.05485-0","volume":"53","author":"A Corcoran","year":"2004","unstructured":"Corcoran A, Doyle S (2004) Advances in the biology, diagnosis and host-pathogen interactions of parvovirus B19. J Med Microbiol 53(Pt 6):459\u2013475","journal-title":"J Med Microbiol"},{"issue":"2","key":"1178_CR4","first-page":"109","volume":"11","author":"PG Corridan","year":"1991","unstructured":"Corridan PG, Laws DE, Morrell AJ, Murray PI (1991) Tonic pupils and human parvovirus (B19) infection. J Clin Neuroophthalmol 11(2):109\u2013110","journal-title":"J Clin Neuroophthalmol"},{"issue":"12","key":"1178_CR5","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1136\/bjo.77.12.829","volume":"77","author":"JH Boer De","year":"1993","unstructured":"De Boer JH, De Keizer RJ, Kijlstra A (1993) In search of intraocular antibody production to parvo B19 virus and adenovirus in intermediate uveitis. Br J Ophthalmol 77(12):829","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"1178_CR6","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1128\/JVI.76.4.2014-2018.2002","volume":"76","author":"S Dorsch","year":"2002","unstructured":"Dorsch S, Liebisch G, Kaufmann B, von Landenberg P, Hoffmann JH, Drobnik W, Modrow S (2002) The VP1 unique region of parvovirus B19 and its constituent phospholipase A2-like activity. J Virol 76(4):2014\u20132018","journal-title":"J Virol"},{"issue":"2","key":"1178_CR7","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/jmv.2047","volume":"65","author":"AM Eis-Hubinger","year":"2001","unstructured":"Eis-Hubinger AM, Reber U, Abdul-Nour T, Glatzel U, Lauschke H, Putz U (2001) Evidence for persistence of parvovirus B19 DNA in livers of adults. J Med Virol 65(2):395\u2013401","journal-title":"J Med Virol"},{"issue":"2","key":"1178_CR8","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1086\/516295","volume":"26","author":"G Enders","year":"1998","unstructured":"Enders G, Dotsch J, Bauer J, Nutzenadel W, Hengel H, Haffner D, Schalasta G, Searle K, Brown KE (1998) Life-threatening parvovirus B19-associated myocarditis and cardiac transplantation as possible therapy: two case reports. Clin Infect Dis 26(2):355\u2013358","journal-title":"Clin Infect Dis"},{"issue":"1","key":"1178_CR9","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/(SICI)1096-9071(200001)60:1<48::AID-JMV9>3.0.CO;2-E","volume":"60","author":"A Hemauer","year":"2000","unstructured":"Hemauer A, Gigler A, Searle K, Beckenlehner K, Raab U, Broliden K, Wolf H, Enders G, Modrow S (2000) Seroprevalence of parvovirus B19 NS1-specific IgG in B19-infected and uninfected individuals and in infected pregnant women. J Med Virol 60(1):48\u201355","journal-title":"J Med Virol"},{"issue":"9107","key":"1178_CR10","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(05)60609-5","volume":"351","author":"JG Hillingso","year":"1998","unstructured":"Hillingso JG, Jensen IP, Tom-Petersen L (1998) Parvovirus B19 and acute hepatitis in adults. Lancet 351(9107):955\u2013956","journal-title":"Lancet"},{"issue":"2","key":"1178_CR11","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1423-0410.1998.7520097.x","volume":"75","author":"J Jordan","year":"1998","unstructured":"Jordan J, Tiangco B, Kiss J, Koch W (1998) Human parvovirus B19: prevalence of viral DNA in volunteer blood donors and clinical outcomes of transfusion recipients. Vox Sang 75(2):97\u2013102","journal-title":"Vox Sang"},{"issue":"9","key":"1178_CR12","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1136\/ard.59.9.672","volume":"59","author":"JR Kerr","year":"2000","unstructured":"Kerr JR (2000) Pathogenesis of human parvovirus B19 in rheumatic disease. Ann Rheum Dis 59(9):672\u2013683","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"1178_CR13","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1093\/rheumatology\/34.9.809","volume":"34","author":"JR Kerr","year":"1995","unstructured":"Kerr JR, Cartron JP, Curran MD, Moore JE, Elliott JR, Mollan RA (1995) A study of the role of parvovirus B19 in rheumatoid arthritis. Br J Rheumatol 34(9):809\u2013813","journal-title":"Br J Rheumatol"},{"issue":"2","key":"1178_CR14","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/jmv.2216","volume":"67","author":"A Knoll","year":"2002","unstructured":"Knoll A, Louwen F, Kochanowski B, Plentz A, Stussel J, Beckenlehner K, Jilg W, Modrow S (2002) Parvovirus B19 infection in pregnancy: quantitative viral DNA analysis using a kinetic fluorescence detection system (TaqMan PCR). J Med Virol 67(2):259\u2013266","journal-title":"J Med Virol"},{"issue":"6","key":"1178_CR15","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/art.10979","volume":"48","author":"HW Lehmann","year":"2003","unstructured":"Lehmann HW, Knoll A, Kuster RM, Modrow S (2003) Frequent infection with a viral pathogen, parvovirus B19, in rheumatic diseases of childhood. Arthritis Rheum 48(6):1631\u20131638","journal-title":"Arthritis Rheum"},{"issue":"12","key":"1178_CR16","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1136\/bjo.83.12.1403","volume":"83","author":"R Maini","year":"1999","unstructured":"Maini R, Edelsten C (1999) Uveitis associated with parvovirus infection. Br J Ophthalmol 83(12):1403\u20131404","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"1178_CR17","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0369-8114(02)00302-4","volume":"50","author":"S Modrow","year":"2002","unstructured":"Modrow S, Dorsch S (2002) Antibody responses in parvovirus B19 infected patients. Pathol Biol (Paris) 50(5):326\u2013331","journal-title":"Pathol Biol (Paris)"},{"issue":"4","key":"1178_CR18","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1128\/JVI.72.4.3018-3028.1998","volume":"72","author":"S Moffatt","year":"1998","unstructured":"Moffatt S, Yaegashi N, Tada K, Tanaka N, Sugamura K (1998) Human parvovirus B19 nonstructural (NS1) protein induces apoptosis in erythroid lineage cells. J Virol 72(4):3018\u20133028","journal-title":"J Virol"},{"issue":"8","key":"1178_CR19","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1128\/JVI.62.8.2884-2889.1988","volume":"62","author":"K Ozawa","year":"1988","unstructured":"Ozawa K, Ayub J, Kajigaya S, Shimada T, Young N (1988) The gene encoding the nonstructural protein of B19 (human) parvovirus may be lethal in transfected cells. J Virol 62(8):2884\u20132889","journal-title":"J Virol"},{"issue":"4","key":"1178_CR20","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF00274934","volume":"12","author":"JG Saal","year":"1992","unstructured":"Saal JG, Steidle M, Einsele H, Muller CA, Fritz P, Zacher J (1992) Persistence of B19 parvovirus in synovial membranes of patients with rheumatoid arthritis. Rheumatol Int 12(4):147\u2013151","journal-title":"Rheumatol Int"},{"issue":"9058","key":"1178_CR21","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0140-6736(96)09110-6","volume":"349","author":"M Soderlund","year":"1997","unstructured":"Soderlund M, von Essen R, Haapasaari J, Kiistala U, Kiviluoto O, Hedman K (1997) Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy. Lancet 349(9058):1063\u20131065","journal-title":"Lancet"},{"issue":"4","key":"1178_CR22","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1046\/j.1423-0410.2003.00299.x","volume":"84","author":"I Thomas","year":"2003","unstructured":"Thomas I, Di Giambattista M, Gerard C, Mathys E, Hougardy V, Latour B, Branckaert T, Laub R (2003) Prevalence of human erythrovirus B19 DNA in healthy Belgian blood donors and correlation with specific antibodies against structural and non-structural viral proteins. Vox Sang 84(4):300\u2013307","journal-title":"Vox Sang"},{"issue":"6","key":"1178_CR23","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1086\/314500","volume":"178","author":"S Venturoli","year":"1998","unstructured":"Venturoli S, Gallinella G, Manaresi E, Gentilomi G, Musiani M, Zerbini M (1998) IgG response to the immunoreactive region of parvovirus B19 nonstructural protein by immunoblot assay with a recombinant antigen. J Infect Dis 178(6):1826\u20131829","journal-title":"J Infect Dis"},{"issue":"5","key":"1178_CR24","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1093\/infdis\/172.5.1356","volume":"172","author":"A Poblotzki von","year":"1995","unstructured":"von Poblotzki A, Hemauer A, Gigler A, Puchhammer-Stockl E, Heinz FX, Pont J, Laczika K, Wolf H, Modrow S (1995) Antibodies to the nonstructural protein of parvovirus B19 in persistently infected patients: implications for pathogenesis. J Infect Dis 172(5):1356\u20131359","journal-title":"J Infect Dis"},{"issue":"9","key":"1178_CR25","doi-asserted-by":"crossref","first-page":"4110","DOI":"10.1128\/JVI.75.9.4110-4116.2001","volume":"75","author":"KA Weigel-Kelley","year":"2001","unstructured":"Weigel-Kelley KA, Yoder MC, Srivastava A (2001) Recombinant human parvovirus B19 vectors: erythrocyte P antigen is necessary but not sufficient for successful transduction of human hematopoietic cells. J Virol 75(9):4110\u20134116","journal-title":"J Virol"},{"issue":"12","key":"1178_CR26","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1046\/j.1537-2995.2001.41121500.x","volume":"41","author":"T Weimer","year":"2001","unstructured":"Weimer T, Streichert S, Watson C, Groner A (2001) High-titer screening PCR: a successful strategy for reducing the parvovirus B19 load in plasma pools for fractionation. Transfusion 41(12):1500\u20131504","journal-title":"Transfusion"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-005-1178-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-005-1178-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-005-1178-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T11:03:59Z","timestamp":1586257439000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-005-1178-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5,20]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["1178"],"URL":"https:\/\/doi.org\/10.1007\/s00417-005-1178-x","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,5,20]]}}}